Gelteq is trading at $0.48, up 5.02%, with biotech-sector strength the clearest available context for its October 28 move; no company-specific announcement explaining the move was found.
- The supplied sector update reports biotech rose 2.18%, while major U.S. indices were nearly flat.
- Broader biotech stocks also rallied on clinical and company news, but this does not establish a direct catalyst for Gelteq.